The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 08, 2025
Filed:
Nov. 13, 2020
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Iwona Wrona, Sharon, MA (US);
Kerem Ozboya, Cambridge, MA (US);
Matthew Lucas, Lexington, MA (US);
Bhaumik Pandya, Bedford, MA (US);
Bertrand Le Bourdonnec, Northborough, MA (US);
Assignee:
JANSSEN PHARMACEUTICA NV, Beerse, BE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); A61K 31/166 (2006.01); A61K 31/17 (2006.01); A61K 31/4188 (2006.01); A61K 31/436 (2006.01); A61K 31/439 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/55 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/501 (2013.01); A61K 31/166 (2013.01); A61K 31/17 (2013.01); A61K 31/4188 (2013.01); A61K 31/436 (2013.01); A61K 31/439 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/497 (2013.01); A61K 31/55 (2013.01); A61K 39/3955 (2013.01);
Abstract
The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.